West Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
West Syndrome pharmacological treatment usually consists in antiepileptic drugs and/or ACTH.
|
31724502 |
2019 |
West Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
Adrenocorticotropic hormone (ACTH) was a treatment of choice, and even in relapse of WS after ACTH therapy, the patients well responded to antiepileptic drugs.
|
11701255 |
2001 |
West Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
Adrenocorticotropin hormone (ACTH) has been the standard treatment to infantile spasms (IS).
|
20042918 |
2010 |
West Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
Adrenocorticotropic hormone (ACTH) therapy is the first-line therapy for infantile spasms, and is effective for many other intractable epilepsies.
|
25149137 |
2015 |
West Syndrome
|
0.400 |
Biomarker
|
disease |
CTD_human |
ACTH-induced seizures in an infant with West syndrome.
|
2554740 |
1989 |
West Syndrome
|
0.400 |
Therapeutic
|
disease |
CTD_human |
ACTH-induced seizures in an infant with West syndrome.
|
2554740 |
1989 |
West Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
Adrenocorticotropic hormone (ACTH) is the only medicine for treating infantile spasms, however, it is catabolized rapidly.
|
28127707 |
2017 |
West Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
Adrenocorticotropic hormone (ACTH), vigabatrin (VGB) and corticosteroids are the first-line treatments for WS.
|
29086890 |
2018 |
West Syndrome
|
0.400 |
Therapeutic
|
disease |
CTD_human |
ACTH therapy in infantile spasms: side effects.
|
6254450 |
1980 |
West Syndrome
|
0.400 |
Biomarker
|
disease |
CTD_human |
ACTH therapy in infantile spasms: side effects.
|
6254450 |
1980 |
West Syndrome
|
0.400 |
Therapeutic
|
disease |
CTD_human |
A fatal incident during combined anticonvulsive therapy with ACTH and Dexamethason prompted us to reevaluate our treatment results in 19 children suffering from infantile spasms.
|
2983143 |
1985 |
West Syndrome
|
0.400 |
Biomarker
|
disease |
CTD_human |
A fatal incident during combined anticonvulsive therapy with ACTH and Dexamethason prompted us to reevaluate our treatment results in 19 children suffering from infantile spasms.
|
2983143 |
1985 |
West Syndrome
|
0.400 |
Therapeutic
|
disease |
CTD_human |
A one-year-old boy presented with hypercalciuria and nephrolithiasis following a course of ACTH therapy for infantile spasms.
|
1324751 |
1992 |
West Syndrome
|
0.400 |
Biomarker
|
disease |
CTD_human |
A one-year-old boy presented with hypercalciuria and nephrolithiasis following a course of ACTH therapy for infantile spasms.
|
1324751 |
1992 |
West Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
At age 6 months, the infant demonstrated infantile spasms and craniosynostosis and was operated on for craniosynostosis and treated with adrenocorticotropic hormone (ACTH) for the infantile spasms.
|
14636357 |
2003 |
West Syndrome
|
0.400 |
Therapeutic
|
disease |
CTD_human |
Cardiac vagal activation by adrenocorticotropic hormone treatment in infants with West syndrome.
|
17287597 |
2007 |
West Syndrome
|
0.400 |
Biomarker
|
disease |
CTD_human |
Cardiac vagal activation by adrenocorticotropic hormone treatment in infants with West syndrome.
|
17287597 |
2007 |
West Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
Comparison of efficacies of zonisamide versus adrenocorticotropic hormone was as following: the cessation of epileptic spasms (27% vs. 40%, p = 0.70), resolution of hypsarrhythmia at 14 days (20% vs. 33%, p = 0.68) and resolution of hypsarrhythmia at 6 weeks (36% vs. 71%, p = 0.14).
|
30293931 |
2019 |
West Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
Effectiveness of corticosteroids versus adrenocorticotropic hormone for infantile spasms: a systematic review and meta-analysis.
|
31657133 |
2019 |
West Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
Efficacy and tolerability of the ketogenic diet versus high-dose adrenocorticotropic hormone for infantile spasms: A single-center parallel-cohort randomized controlled trial.
|
30801699 |
2019 |
West Syndrome
|
0.400 |
Therapeutic
|
disease |
CTD_human |
Given the very poor prognosis of infantile spasms especially in such conditions as cerebral palsy, the combination of ACTH and vigabatrin appears to be an interesting therapy advance with very few side effects.
|
8980841 |
1997 |
West Syndrome
|
0.400 |
Biomarker
|
disease |
CTD_human |
Given the very poor prognosis of infantile spasms especially in such conditions as cerebral palsy, the combination of ACTH and vigabatrin appears to be an interesting therapy advance with very few side effects.
|
8980841 |
1997 |
West Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
Her infantile spasms and hypsarrhythmia disappeared promptly by adrenocorticotropic hormone therapy (CORTROSYN®Z, 0.0125mg/kg/day daily for 2weeks intramuscularly), though the administration of pyridoxal phosphate and valproic acid had poor efficacy.
|
28551038 |
2017 |
West Syndrome
|
0.400 |
Therapeutic
|
disease |
CTD_human |
Hormonal background of the hypertension and fluid derangements associated with adrenocorticotrophic hormone treatment of infants.
|
2551692 |
1989 |
West Syndrome
|
0.400 |
Biomarker
|
disease |
CTD_human |
Hormonal background of the hypertension and fluid derangements associated with adrenocorticotrophic hormone treatment of infants.
|
2551692 |
1989 |